Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1984 Jun;60(3):171–174. doi: 10.1136/sti.60.3.171

Metronidazole in the treatment of non-specific vaginitis (NSV).

F Jerve, T B Berdal, P Bohman, C C Smith, O K Evjen, H Gjønnaess, M Gaasemyr, L Hausken, K Hesla, E Hoftvedt, et al.
PMCID: PMC1046293  PMID: 6375804

Abstract

In a large multicentre study of 429 patients with the usual signs and symptoms of non-specific vaginitis (NSV), we studied the effect of different doses of metronidazole. The patients were divided into five treatment groups as follows: group A was given 400 mg metronidazole three times daily for seven days, group B 2000 mg as a single dose, group C 2000 mg on days 1 and 2, group D 2000 mg on days 1 and 3, and group E was given 1200 mg metronidazole once daily for five days. At follow up examination four weeks from the start of treatment, patients in groups D and E showed the best clinical results with cure rates of 94.0% and 93.6% respectively. In addition the rate of reisolation of Gardnerella vaginalis was lowest in group D. We therefore recommend metronidazole 2000 mg on days 1 and 3 as routine treatment for non-specific or vaginitis associated with gardnerella.

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balsdon M. J., Taylor G. E., Pead L., Maskell R. Corynebacterium vaginale and vaginitis: a controlled trial of treatment. Lancet. 1980 Mar 8;1(8167):501–503. doi: 10.1016/s0140-6736(80)92762-2. [DOI] [PubMed] [Google Scholar]
  2. Easmon C. S., Ison C. A., Kaye C. M., Timewell R. M., Dawson S. G. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. Br J Vener Dis. 1982 Aug;58(4):246–249. doi: 10.1136/sti.58.4.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GARDNER H. L., DUKES C. D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955 May;69(5):962–976. [PubMed] [Google Scholar]
  4. Koch-Weser J., Goldman P. Drug therapy: metronidazole. N Engl J Med. 1980 Nov 20;303(21):1212–1218. doi: 10.1056/NEJM198011203032106. [DOI] [PubMed] [Google Scholar]
  5. Malouf M., Fortier M., Morin G., Dube J. L. Treatment of Hemophilus vaginalis vaginitis. Obstet Gynecol. 1981 Jun;57(6):711–714. [PubMed] [Google Scholar]
  6. Pheifer T. A., Forsyth P. S., Durfee M. A., Pollock H. M., Holmes K. K. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978 Jun 29;298(26):1429–1434. doi: 10.1056/NEJM197806292982601. [DOI] [PubMed] [Google Scholar]
  7. Shaw C. E., Forsyth M. E., Bowie W. R., Black W. A. Rapid presumptive identification of Gardnerella vaginalis (Haemophilus vaginalis) from human blood agar media. J Clin Microbiol. 1981 Jul;14(1):108–110. doi: 10.1128/jcm.14.1.108-110.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Spiegel C. A., Amsel R., Eschenbach D., Schoenknecht F., Holmes K. K. Anaerobic bacteria in nonspecific vaginitis. N Engl J Med. 1980 Sep 11;303(11):601–607. doi: 10.1056/NEJM198009113031102. [DOI] [PubMed] [Google Scholar]
  9. Vontver L. A., Eschenbach D. A. The role of Gardnerella vaginalis in nonspecific vaginitis. Clin Obstet Gynecol. 1981 Jun;24(2):439–460. doi: 10.1097/00003081-198106000-00009. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES